1st Quarter - Report

AMERICAN MEDICAL ASSOCIATION for AMERICAN MEDICAL ASSOCIATION

Firm
Client
Income
—
Expenses
$6,720,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Electronic Health Records/Meaningful Use - anticompetitive issues

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
GEORGE E COX —
RICHARD A DEEM —
MARGARET D GARIKES —
KRISTEN O'BRIEN —
MARI SAVICKIS —

Contacted: Government Accountability Office (GAO); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); White House Office; Indian Health Service; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); SENATE; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS)

Education EDU

H.R.1117, Creating Access to Residency Education Act of 2015, all provisions H.R.2, Medicare Access and CHIP Reauthorization Act of 2015, provision relating to Community Health Centers/GME Graduate Medical Education

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
GEORGE E COX —
RICHARD A DEEM —
JASON MARINO —
KRISTEN O'BRIEN —
THOMAS CORDREY ROBERGE —
ANDREW WANKUM —

Contacted: Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Environmental Protection Agency (EPA); Indian Health Service; Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; Federal Trade Commission (FTC); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 1117 (114th), H.R. 2 (114th)

Health Issues HCR

S.524, Comprehensive Addiction and Recovery Act of 2015, all provisions H.R.1270, Restoring Access to Medication Act of 2015, all provisions S.709, Restoring Access to Medication Act of 2015, all provisions H.R.293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions S.36, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015, all provisions 21st Century Cures draft legislation - FDA reforms, telemedicine, LDTs Electronic Health Records - Meaningful Use HHS Payment Learning and Action Network Alternative Payment Models Prescription Drug Diversion Prescription Drug Abuse ICD-10 Repeal Physician-Owned Hospitals Prescription requirements for OTC medications Indian Health Service - Purchased and Referred Care payment rates Cybersecurity EHR/Meaningful Use Interoperability FDA/NIH Modernization Laboratory Developed Tests (LDTs) Telemedicine Opioid Abuse Precision Medicine Next Generation Sequencing Antibiotic Stewardship Healthcare Disparities Hypertension Pre-Diabetes HIPAA Privacy Ebola Navajo Birth Cohort funding

Contacted: Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); White House Office; Indian Health Service; Office of Natl Drug Control Policy (NDCP); SENATE; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: S. 524 (114th), S. 709 (114th), H.R. 1270 (114th), H.R. 293 (114th), S. 36 (114th)

Veterans VET

Veterans Administration Reform Veterans' Choice Program

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
RICHARD A DEEM —
MARGARET D GARIKES —
JASON ALAN SCULL —

Contacted: Office of Natl Drug Control Policy (NDCP); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Indian Health Service; SENATE; Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); White House Office; Centers For Disease Control & Prevention (CDC)

Medicare/Medicaid MMM

H.R.1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions S.810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions H.R.2, Medicare Access and CHIP Reauthorization Act of 2015, all provisions H.R.1021, Protecting the Integrity of Medicare Act of 2015, all provisions H.R.1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions S.141, Protecting Seniors' Access to Medicare Act of 2015, all provisions H.R.592, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions H.R.270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R.1220, Removing Barriers to Colorectal Cancer Screening Act of 2015, all provisions S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015, all provisions Medicare program: SGR Repeal Medicare program: ICD-10 Repeal Medicare program: Medicare Advantage Medicare program: Physician Payment Sunshine Act reforms Medicare program: Protecting Access to Medicare Act Medicare program: Durable Medical Equipment Face-to-Face Encounter requirement Medicare program: In-Office Ancillary Services Exception Medicare program: Global Surgical Services unbundling Medicare program: EHR Certification Medicare program: Physician Quality Reporting System Medicare program: Quality measure alignment Medicare program: Value-based modifier Medicare program: Physician Compare Medicare program: Medicare physician data Medicare program: Accountable Care Organizations Medicare program: Alternative payment models Medicare program: EHR/Meaningful Use Interoperability Medicare program: Program Integrity Medicare program: RUC Medicare program: Drug payment policy Medicare program: HIPAA Medicare program: Regulatory relief Medicare program: Home Health Medicare program: Prior authorization and prepayment demonstrations Medicare program: Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Medicare and Medicaid programs: EHER/Meaningful Use regulations Medicare and Medicaid programs: Cybersecurity Medicare and Medicaid programs: HHS Payment Learning and Action Network

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Indian Health Service; White House Office; Government Accountability Office (GAO); Federal Trade Commission (FTC); Environmental Protection Agency (EPA); SENATE

Bills named: S. 141 (114th), H.R. 592 (114th), S. 810 (114th), S. 624 (114th), H.R. 2 (114th), H.R. 270 (114th), H.R. 1190 (114th), H.R. 1220 (114th), H.R. 1470 (114th), H.R. 1021 (114th)

Torts TOR

H.R.865, Good Samaritan Health Professionals Act of 2015, all provisions S.689, Sports Medicine Licensure Clarity Act, all provisions S.707, Opioid Overdose Reduction Act of 2015, all provisions Medical Liability Reform

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
DEBRA A COHN —
GEORGE E COX —
RICHARD A DEEM —
THOMAS CORDREY ROBERGE —

Contacted: Indian Health Service; Medicare Payment Advisory Commission (MedPAC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Federal Trade Commission (FTC); SENATE; White House Office; Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 865 (114th), S. 707 (114th), S. 689 (114th)

Clean Air and Water (quality) CAW

Ozone National Ambient Air Quality Standards

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
DEBRA A COHN —
GEORGE E COX —
RICHARD A DEEM —

Contacted: Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Environmental Protection Agency (EPA); Indian Health Service; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.